Literature DB >> 3418616

Suppression of in vitro lymphocyte reactivity to phytohemagglutinin by placental protein 14.

A G Pockley1, E A Mowles, R J Stoker, O M Westwood, M G Chapman, A E Bolton.   

Abstract

Crude human decidual extracts containing up to 26.6 mg/l of placental protein 14 (PP14) and purified PP14 were assessed for their effects on the in vitro lymphocyte reactivity to phytohemagglutinin (PHA). Both decidual extract and purified PP14 suppressed the mitogenic response to PHA with the suppression being dose-dependent over the range of PP14 concentrations investigated (0-26.6 mg/l). On the specific reduction of the PP14 content by a monoclonal anti-PP14 immunoadsorbant the suppression was reduced. The suppressive activity of PP14 was related to the degree of proliferation of the stimulated lymphocytes. These results suggest that PP14, which is present at peak levels in the first trimester of pregnancy and constitutes up to 10% of the soluble protein content of decidual tissue, may be an immunomodulator important for the survival of the implanting embryo and maintenance of early pregnancy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3418616     DOI: 10.1016/0165-0378(88)90046-0

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  8 in total

1.  alpha2-macroglobulin modulates the immunoregulatory function of the lipocalin placental protein 14.

Authors:  G J Riely; J Rachmilewitz; P H Koo; M L Tykocinski
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

2.  Placental protein 14 (PP14) inhibits the synthesis of interleukin-2 and the release of soluble interleukin-2 receptors from phytohaemagglutinin-stimulated lymphocytes.

Authors:  A G Pockley; A E Bolton
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

Review 3.  A pregnant possibility: crossing fetal tolerance with hematopoiesis.

Authors:  P Furmanski
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

4.  Immunohistochemistry, glycosylation and immunosuppression of glycodelin in human ovarian cancer.

Authors:  Udo Jeschke; Ioannis Mylonas; Christiane Kunert-Keil; Renate Stahn; Christoph Scholz; Wolfgang Janni; Christina Kuhn; Eike Schröder; Doris Mayr; Klaus Friese
Journal:  Histochem Cell Biol       Date:  2008-10-14       Impact factor: 4.304

5.  Glycodelin and amniotic fluid transferrin as inhibitors of E-selectin-mediated cell adhesion.

Authors:  Udo Jeschke; Xiaoyu Wang; Volker Briese; Klaus Friese; Renate Stahn
Journal:  Histochem Cell Biol       Date:  2003-05-13       Impact factor: 4.304

6.  The effect of human placental protein 14 (PP14) on the production of interleukin-1 from mitogenically stimulated mononuclear cell cultures.

Authors:  A G Pockley; A E Bolton
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

Review 7.  The Roles of Glycodelin in Cancer Development and Progression.

Authors:  Juan Cui; Yanguo Liu; Xiuwen Wang
Journal:  Front Immunol       Date:  2017-11-29       Impact factor: 7.561

8.  Manifestations of immune tolerance in the human female reproductive tract.

Authors:  Gary F Clark; Danny J Schust
Journal:  Front Immunol       Date:  2013-02-13       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.